These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 32579277

  • 1. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
    Chen X, Chen S, Shen T, Yang W, Chen Q, Zhang P, You Y, Sun X, Xu H, Tang Y, Mi J, Yang Y, Ling W.
    FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
    [Abstract] [Full Text] [Related]

  • 2. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
    Gu L, Ding X, Wang Y, Gu M, Zhang J, Yan S, Li N, Song Z, Yin J, Lu L, Peng Y.
    Int J Biol Sci; 2019 Aug; 15(13):2815-2829. PubMed ID: 31853220
    [Abstract] [Full Text] [Related]

  • 3. Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation.
    Zhang C, Zhang Q, Huang Z, Jiang Q.
    J Endocrinol; 2020 Aug; 246(2):109-122. PubMed ID: 32485680
    [Abstract] [Full Text] [Related]

  • 4. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
    Jeong KJ, Kim DY, Quan HY, Jo HK, Kim GW, Chung SH.
    Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
    [Abstract] [Full Text] [Related]

  • 5. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S, Li W, Yu Y, Yao F, A L, Lan X, Guan F, Zhang M, Chen L.
    Life Sci; 2015 Oct 15; 139():8-15. PubMed ID: 26285176
    [Abstract] [Full Text] [Related]

  • 6. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
    Sun WX, Lou K, Chen LJ, Liu SD, Pang SG.
    J Endocrinol Invest; 2021 Aug 15; 44(8):1753-1765. PubMed ID: 33423221
    [Abstract] [Full Text] [Related]

  • 7. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 8. The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity.
    Gao S, Ghoshal S, Zhang L, Stevens JR, McCommis KS, Finck BN, Lopaschuk GD, Butler AA.
    J Biol Chem; 2019 Sep 06; 294(36):13366-13377. PubMed ID: 31324719
    [Abstract] [Full Text] [Related]

  • 9. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP, Lee MC, Foufelle F, Sajan J, Cleland C, Farese RV.
    Cell Signal; 2018 Mar 06; 43():62-70. PubMed ID: 29269047
    [Abstract] [Full Text] [Related]

  • 10. Saponarin activates AMPK in a calcium-dependent manner and suppresses gluconeogenesis and increases glucose uptake via phosphorylation of CRTC2 and HDAC5.
    Seo WD, Lee JH, Jia Y, Wu C, Lee SJ.
    Bioorg Med Chem Lett; 2015 Nov 15; 25(22):5237-42. PubMed ID: 26471090
    [Abstract] [Full Text] [Related]

  • 11. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
    Lee JM, Han HS, Jung YS, Harris RA, Koo SH, Choi HS.
    J Biol Chem; 2018 Aug 24; 293(34):13125-13133. PubMed ID: 29950523
    [Abstract] [Full Text] [Related]

  • 12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ.
    Clin Sci (Lond); 2015 Nov 24; 129(10):839-50. PubMed ID: 26201094
    [Abstract] [Full Text] [Related]

  • 13. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M, Stewart-Fitzgibbon R, Fu J, Akhmedov D, Rajendran K, Mendoza-Rodriguez MG, Rivera-Molina YA, Gibson M, Berglund ED, Justice NJ, Berdeaux R.
    Mol Metab; 2016 Jan 24; 5(1):34-46. PubMed ID: 26844205
    [Abstract] [Full Text] [Related]

  • 14. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
    Yadav H, Devalaraja S, Chung ST, Rane SG.
    J Biol Chem; 2017 Feb 24; 292(8):3420-3432. PubMed ID: 28069811
    [Abstract] [Full Text] [Related]

  • 15. Cystathionine γ-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.
    Guo W, Li D, You Y, Li W, Hu B, Zhang S, Miao L, Xian M, Zhu Y, Shen X.
    FASEB J; 2019 Mar 24; 33(3):4212-4224. PubMed ID: 30526049
    [Abstract] [Full Text] [Related]

  • 16. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
    Besse-Patin A, Jeromson S, Levesque-Damphousse P, Secco B, Laplante M, Estall JL.
    Proc Natl Acad Sci U S A; 2019 Mar 05; 116(10):4285-4290. PubMed ID: 30770439
    [Abstract] [Full Text] [Related]

  • 17. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
    Qiao A, Ma W, Jiang Y, Han C, Yan B, Zhou J, Qin G.
    Int J Mol Sci; 2022 Sep 29; 23(19):. PubMed ID: 36232770
    [Abstract] [Full Text] [Related]

  • 18. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose.
    Dihingia A, Ozah D, Ghosh S, Sarkar A, Baruah PK, Kalita J, Sil PC, Manna P.
    J Nutr Biochem; 2018 Feb 29; 52():103-114. PubMed ID: 29175667
    [Abstract] [Full Text] [Related]

  • 19. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
    Lee JM, Seo WY, Song KH, Chanda D, Kim YD, Kim DK, Lee MW, Ryu D, Kim YH, Noh JR, Lee CH, Chiang JY, Koo SH, Choi HS.
    J Biol Chem; 2010 Oct 15; 285(42):32182-91. PubMed ID: 20688914
    [Abstract] [Full Text] [Related]

  • 20. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
    Li H, Xu M, Lee J, He C, Xie Z.
    Am J Physiol Endocrinol Metab; 2012 Nov 15; 303(10):E1234-44. PubMed ID: 22967499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.